
X
Sanofi hands back gene therapies to Oxford Biomedica
https://pharmaphorum.com/news/sanofi-hands-back-gene-therapies-to-oxford-biomedica/
French pharma makes move into haemophilia market.
2017 could be a bumper year for M&A – but Trump’s price control threats dominate
Coming antibody drugs and gene therapy could transform treatment